Overview

Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy of soy/isoflavone supplementation on hot flashes in men who are being treated with luteinizing hormone-releasing hormone (LHRH) agonist therapy for control of advanced prostate cancer
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas
Collaborator:
Amgen
Treatments:
Androgens